ホームページへ
4.6/5
TrustPilot

アンカラで最高の白血病化学療法医師 - トップ1名の医師

トルコのトップ白血病化学療法医師と価格を比較。こちらで最適なマッチングを見つけてください

トルコの3名のトップ白血病化学療法専門家から見積もりを取得

ご要望と予算に基づいて最適な医師を厳選いたします

トップ医師

1

トルコ

レビュー

14000+

実際の患者より

医師サービスで最良価格の国を選択

トップ各国の白血病化学療法価格を比較

国をタップしてトップ医師と価格を表示

Ukraine
United Kingdom
Poland
Czech Republic
Mexico
Turkey
$3,200 - $6,500
$5,000 - $10,000
$5,000 - $10,000
$7,000 - $11,000
$7,500 - $12,500
$8,000 - $16,000
$0
$4,000
$8,000
$12,000
$16,000

トルコの白血病化学療法でBookimed患者が実際に支払う費用

最も人気の範囲

$15K+

$30K+

$45K+

$75K+

$105K+

$10,000 – $43,000

ほとんどの患者がこの範囲内でお支払いです

正確な費用は選択された医師、技術、治療部位、お客様の個別ニーズによって決まります

お客様のケースに正確な見積もりを取得

個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし

Osman Ilhan

  • 48年の経験
  • 認定:
  • 所在地: トルコ, アンカラ
  • Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

    His medical interests include:

    Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

    Acute Leukemia

    Chronic Leukemia Treatments

    Hodgkin Lymphoma

    Non-Hodgkin Lymphoma Treatments

    Multiple Myeloma Treatments, MDS

    Aplastic Anemia

    ITP

    TTP Treatments

    Hypercoagulability

    Hereditary Thrombophilia Treatments

    Therapeutic Apheresis

    Photopheresis

    Geriatric Hematology Diseases.

  • 続きを読む
診察
お問い合わせください

海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。

ヤン・マツィイフスキー

医療コーディネーターチーム責任者

4300+件以上の患者の旅をガイド

Bookimedで3

Turkeyの278名の患者が今月当社を通じて医師を見つけました

完璧な医師マッチングを取得する方法

1

2分のクイズ

目標、予算、スケジュールをお聞かせください

2

人間のマッチング + AI

アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します

3

オプション準備完了

価格、パッケージ、日程を比較。コーディネーターとチャット

選択肢に迷っていますか?

専属の Bookimedコーディネーターがお客様のニーズに合わせた完璧な外科医を見つけるお手伝いをします

  • すべての段階で24時間365日サポート
  • 医師とのマッチングサポートとクリニックとの全てのコミュニケーションを処理
  • 旅行、宿泊、送迎を調整します

治療をガイド

医療訓練を受けた専属コーディネーター

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

適切な医師とクリニックの選び方:内部者のヒント

医師やクリニックを選ぶ際は、これらの重要なポイントを覚えておいてください:
資格を確認
ISAPS、JCI、または関連医学会などの機関からの認証を確認してください
成功率を確認
お客様の特定治療に豊富な経験と実績のある医師をお選びください
患者レビューを読む
実際の患者様のBookimedレビューをご覧になり、体験について学んでください
効果的なコミュニケーションの確保
円滑な治療のため言語サポートを提供するクリニックを選んでください。
サービスについて質問
隠れた費用を避けるため、価格に宿泊、現地送迎、アフターケアなどのサービスが含まれているかご確認ください

Bookimed洞察:トルコのトップ白血病化学療法専門家(2026)

Bookimedはトルコの白血病化学療法リクエスト3件を調整し、1名のトップ評価専門家と協力しています。この表の医師は国際的資格、臨床専門知識、患者の結果に基づいて選ばれています。2026年ランキングは実際の患者ケースとパートナークリニックの現行プログラムからの検証済みデータを使用して形成されています
順位医師経験適合する方特色クリニックと所在地診察

FAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

What specific types of doctors handle leukemia chemotherapy in Turkey?

Leukemia chemotherapy in Turkey is managed by hematologist-oncologists and pediatric hematologists who specialize in blood-borne malignancies. These experts complete intensive sub-specialty fellowships in internal medicine or pediatrics followed by dedicated training in bone marrow disorders and systemic anticancer therapies.

  • Hematologist-oncologists: Internal medicine specialists with dual fellowships in blood disorders and oncology treatments.
  • Pediatric hematologists: Doctors like Dr. Birol Baytan who manage childhood-specific protocols for acute leukemia.
  • BMT specialists: Experts in stem cell transplantation often integrated into high-dose chemotherapy programs.
  • Multidisciplinary boards: Medical oncologists and specialist nurses collaborate to design personalized chemotherapy regimens.

Bookimed Expert Insight: Many top Turkish hematologists have gained international exposure at institutions like MD Anderson or Harvard. For instance, Dr. Zafer Gulbas and Dr. Osman Ilhan were part of the teams that performed Turkey's first bone marrow transplants. Choosing a doctor with this level of academic leadership ensures access to protocols that meet global standards.

Patient Consensus: Patients often mention feeling reassured by the deep specialization of their care teams. They note that doctors explain exactly how chemotherapy interacts with bone marrow health. Many were surprised by how closely hematologists and transplant specialists work together during the entire process.

What global qualifications and training do Turkish leukemia doctors have?

Turkish leukemia doctors undergo rigorous 12-year training tracks that align with European and American standards. They hold domestic board certifications and international credentials. Many specialists complete fellowships at top institutions like MD Anderson Cancer Center and Harvard-affiliated Dana-Farber Cancer Institute.

  • International training: Professors train at premier centers in the USA, UK, Israel, and Japan.
  • Global certifications: Specialists hold European Hematology Association (EHA) and European Medical Oncology certificates.
  • Academic leadership: Doctors publish over 50 peer-reviewed articles and lead national stem cell donor banks.
  • Clinical accreditation: Specialists operate in hospitals with JCI, ESMO, and Newsweek Best Hospitals recognition.

Bookimed Expert Insight: Data reveals that top Turkish hematologists often hold dual expertise in both clinical treatment and laboratory research. For instance, Dr. Zafer Gulbas and Dr. Osman Ilhan pioneered the country's first stem cell transplant programs. These leaders often manage over 3,000 procedures and maintain success rates around 81% for complex autologous transplants.

Patient Consensus: Patients note that major Turkish centers follow strict international chemo protocols and use advanced mutation testing. They often feel reassured by the fast, protocol-driven approach of the medical teams. Many suggest choosing major university hospitals where multidisciplinary teams handle complex childhood and adult leukemia cases.

Which Turkish doctors are most recognized for leukemia chemotherapy and bone marrow transplants?

Turkish hematologists excel in leukemia chemotherapy and transplants due to international training and high-volume experience. Dr. Zafer Gulbas at Anadolu Medical Center and Dr. Osman Ilhan at Private Koru Ankara Hospital are pioneers in stem cell technology. These specialists lead JCI-accredited units following global protocols.

  • Expert background: Dr. Zafer Gulbas trained at Fred Hutchinson and MD Anderson Cancer Center.
  • Transplant volume: Dr. Gulbas founded a center performing 3,000+ bone marrow transplants since 2010.
  • Surgical innovation: Dr. Osman Ilhan performed the first bone marrow stem cell transplant in Turkey.
  • Specialized training: Dr. Serdar Bedii Omay at Emsey Hospital holds a PhD from Japan.

Bookimed Expert Insight: Data shows a concentration of expertise in Istanbul and Ankara at centers affiliated with US institutions. Dr. Zafer Gulbas and Dr. Eda Tanrikulu work at Anadolu Medical Center, an official Johns Hopkins Medicine International partner. This connection ensures patients receive chemotherapy protocols identical to those used in top American hospitals.

Patient Consensus: Patients emphasize choosing centers where the same hematologist manages both chemotherapy and transplant planning. They note that integrated infection control and rapid donor matching significantly reduce overall treatment timelines. Many feel more confident when doctors have documented training from major programs in the USA or Canada.

Do leukemia doctors in Turkey speak English?

Leukemia doctors in Turkey frequently speak fluent English due to overseas training. Many hematologists hold memberships in international bodies like the European Hematology Association (EHA). These specialists often complete fellowships in the USA or Canada to master complex chemotherapy protocols.

  • International training: Professors often train at US centers like MD Anderson or Fred Hutchinson.
  • Global memberships: Leading doctors belong to the American Society of Clinical Oncology (ASCO).
  • Language support: JCI-accredited hospitals provide professional medical interpreters for all patient consultations.
  • Document translation: Clinics translate diagnostic reports and discharge summaries between English and Turkish.

Bookimed Expert Insight: Data shows top hematologists often have deep ties to North American medicine. For example, Dr. Zafer Gulbas at Anadolu Medical Center trained in Toronto and Seattle. His clinic is an official partner of Johns Hopkins Medicine. This level of collaboration ensures that medical language and treatment standards match Western expectations.

Patient Consensus: Patients note that doctors explain complex blood test results in clear English. They feel relieved when specialists use familiar medical terms during rounds. Many travelers found the hospital translators helpful for navigating daily needs outside of medical talks.